Unicycive Therapeutics (UNCY) Proxy filing summary

Voting matters and shareholder proposals

• Three directors were elected to serve until the 2027 Annual Meeting or until successors are appointed, with detailed vote counts provided for each nominee.

• The appointment of Grassi & Co. CPAs, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified by shareholders, with the majority voting in favor.

Board of directors and corporate governance

• Directors elected include Dr. Shalabh Gupta, Dr. Sandeep Laumas, and D. Sarawati Kenkare-Mitra, each receiving a majority of votes cast.

Audit committee and external auditor matters

• Grassi & Co. CPAs, P.C. was approved as the external auditor for the upcoming fiscal year, with minimal opposition and abstentions.